The 5th annual Patients as Partners program is the only conference in the US that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.

Featured Speakers

Ken Getz, MBA
Roslyn Schneider, MD
Mary Stober Murray
Bristol-Myers Squibb
Beth Zaharoff
Marc Boutin, JD
National Health Council
Geraldine Blavat
Patient and Advocate
Stefanie Joho
Survivor and Advocate
Meyer Carol colorCarol Meyer

– Overview –

Patients as Partners is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum.

  1. Patients as Partners US is accredited by Patients Included and addresses what matters most to patients to enable them to support clinicalresearch:
    1. Understanding and incorporating the patient’s voice in designing clinical trials and developing a clinical endpoint
    2. Vastly improving the patient’s entire experience in a clinical trial
    3. Empowering the patient in the new medicines development process
  2.  We are pleased to bring back “Ask the Patient” to Patients as Partners US, a program representing a group of individuals who’ve experienced a clinical trial.These patients, our Medical Heroes, will be available to answer questions about their clinical trial experience. It is a great opportunity to learn about the realities of a clinical trial directly from the patient’s point of view. They will have a badge identifying their participation and will be available throughout the conference. We will also have an area in the exhibit hall to meet them during breaks.
  3. The conference room will be set up in rounds for easier interaction and each table will be provided with a paper “Tool-Box” and an assortment of specially designed materials to help capture ideas.
    • Each session will conclude with a list of key take-aways presented from the session representative.
    • Result: Each attendee will walk away with a toolbox full of ideas that will support their patient involvement initiatives.

Turning  Discussion Into Action

Dr Theresa Mullin, FDA, delivered a progress report on PDUFA VI and an update on the new performance and procedural goal at the 2017 conference.

Ken Getz, Tufts CSDD, CISCRP, delivered a presentation on raising awareness in clinical research at the 2017 conference.

Marilyn Metcalf, GSK, led a patient and researcher panel on the medicine information exchange at the 2017 conference.

A multi-stakeholder panel addressing patient and industry needs in medicines development.
From left to right: Ken Getz, Tufts, CISCRP, T.J. Sharpe, Patient and Advocate, Durhane Wong-Reiger, PhD, Canadian Organization for Rare Disorders, Jean McCoy, Health Advocacy Strategies, Janet Freeman-Daily, Lung Cancer Patient and Activist, Marilyn Metcalf, GSK


A special thanks to our advisors for their unwavering guidance and expertise in helping us with the research to craft an in-depth agenda that puts the “discussion” around patient involvement into action across the entire clinical development continuum.

We look forward to seeing you in Philadelphia, March 15-16, 2018.


 kate-bw-3Kate Woda
Conference Director
Valerie Bowling New 

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Business Development 

Kim Chin
Marketing Director

 elizabeth-bard-bw-2Elizabeth Bard
Business Development Manager
 jackiedt-bwJackie Della Torre
Business Development Manager

Nancy Belis
Senior Conference Planner

Laura Mulchay 

Laura Mulchay 
Marketing Associate